helenalin has been researched along with thromboxane b2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leven, W; Lösche, W; Schröder, H; Schrör, K; Strobach, H; Till, U; Willuhn, G | 1 |
1 other study(ies) available for helenalin and thromboxane b2
Article | Year |
---|---|
Helenalin and 11 alpha,13-dihydrohelenalin, two constituents from Arnica montana L., inhibit human platelet function via thiol-dependent pathways.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cysteine; Humans; Phospholipases A; Phospholipases A2; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin; Sesquiterpenes; Sesquiterpenes, Guaiane; Sulfhydryl Reagents; Thromboxane B2 | 1990 |